Exogenus Therapeutics
The startup has developed an exosome-based platform that utilizes proprietary vesicles with regenerative, anti-inflammatory, and immunomodulatory properties to create therapeutic products. This technology provides healthcare providers with targeted treatment options for skin and autoimmune diseases.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$980KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an exosome-based platform that utilizes proprietary vesicles with regenerative, anti-inflammatory, and immunomodulatory properties to create therapeutic products. This technology provides healthcare providers with targeted treatment options for skin and autoimmune diseases.